DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
Funds / Blackstone Life Sciences VI - B L.P.
Blackstone Life Sciences VI - B L.P.
Fundraisingbuyout or unlabelledmanager not yet resolvedDelaware
Amounts, each with its basis
- Vintage
- 2025basis: Form D first sale
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $6.3Bwhat may be sold, not what was raised
- Form D sold
- $6.3Bas of the filing of Apr 2, 2026, 1 investors
- First sale
- Nov 7, 2025
- Reported gross assets
- unknownForm ADV; not fund size, not dry powder
- Peak reported gross assets
- unknownhighest year on the reporting tape
- Owners (ADV)
- unknown
- Reported on ADV
- unknown
Lifecycle
Fundraising
rule: recent Form D and no reported gross assetsmodel: lc-pe-1gav path: as of year: n/aform d latest: 2026-04-02reported years: 0first reported year: n/a
Reported gross assets by year
0 annual rows
No Form ADV reporting row for this fund. It may be known from Form D only.
Placement agents and principals
0 placement agents, 16 principals
- Elsa G. Gelin Executive Officer
- Alicia Novak Executive Officer
- Eric G. Liaw Executive Officer
- Victoria G. Portnoy Executive Officer
- Nentcho G. Nentchev Executive Officer
- Chris G. Placca Executive Officer
- Nicholas G. Galakatos Executive Officer
- John G. Finley Executive Officer
- Robert G. Liptak Executive Officer
- Christopher G. Striano Executive Officer
- Mathias G. Favetto Executive Officer
- Omar G. Rehman Executive Officer
- Blackstone Life Sciences Associates VI L.P. Promoter
- Bxls VI L.L.C. Promoter
- Joseph Baratta Executive Officer
- Ilan G. Halal Executive Officer
Limited partners
0 disclosed
No LP commitment to this fund collected yet. An LP appears only when a public disclosure names this fund.
Investments attributed to this fund
0
No investment attributed to this fund. A firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Events
1 most recent
- Apr 2, 2026Blackstone Life Sciences VI - B L.P. Form D/A: Form D amount sold up $2,684,701,707 to $6,300,000,000 (previous filing $3,615,298,293)Fund form d amended Fact SEC EDGAR Form D data sets (quarterly)